WO2023031082 - DEVICE FOR ADMINISTERING A PHARMACEUTICAL SUSPENSION
National phase entry:
Publication Number
WO/2023/031082
Publication Date
09.03.2023
International Application No.
PCT/EP2022/073887
International Filing Date
29.08.2022
Title **
[English]
DEVICE FOR ADMINISTERING A PHARMACEUTICAL SUSPENSION
[French]
DISPOSITIF D'ADMINISTRATION D'UNE SUSPENSION PHARMACEUTIQUE
Applicants **
NOVO NORDISK A/S
Inventors
BENGTSSON, Henrik
DEHLI, Jeppe, Ibsen
HELBO, Janus
EGENFELDT, Svend
WINDUM, Jesper, Peter
Priority Data
21194033.3
31.08.2021
EP
21210767.6
26.11.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2394 | |
| EPO | Filing, Examination, Granting | 9475 | |
| Japan | Filing, Examination, Granting | 2229 | |
| South Korea | Filing, Examination, Granting | 2282 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,120
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention provides a dose delivery device (1, 100, 200, 300, 400) comprising: a variable volume reservoir (10, 110, 210, 310, 410) holding a pharmaceutical suspension and comprising an outlet (12, 112, 212, 312, 412), a dose expelling mechanism adapted for activation to expel a volume of the pharmaceutical suspension through the outlet (12, 112, 5 212, 312, 412), and a dose preparation system comprising a preparation member (30, 130, 230, 330, 430) operable prior to activation of the dose expelling mechanism to enable administration of the volume of the pharmaceutical suspension to a subject, wherein the dose preparation system further comprises an agitation member (40, 140, 240, 340, 440) capable of agitating relative motion with respect to the variable volume reservoir (10, 110, 210, 310, 10 410), the agitating relative motion causing a re-suspending agitation of the pharmaceutical suspension, and wherein the agitation member (40, 140, 240, 340, 440) is operatively coupled with the preparation member (30, 130, 230, 330, 430) and configured to undergo said agitating relative motion in response to the operation of the preparation member (30, 130, 230, 330, 430).[French]
La présente invention concerne un dispositif de distribution de dose (1, 100, 200, 300, 400) comprenant : un réservoir à volume variable (10, 110, 210, 310, 410) contenant une suspension pharmaceutique et comprenant une sortie (12, 112, 212, 312, 412), un mécanisme d'expulsion de dose conçu pour être activé afin d'expulser un volume de la suspension pharmaceutique à travers la sortie (12, 112, 5 212, 312, 412), et un système de préparation de dose comprenant un élément de préparation (30, 130, 230, 330, 430) pouvant fonctionner avant l'activation du mécanisme d'expulsion de dose pour permettre l'administration du volume de la suspension pharmaceutique à un sujet, le système de préparation de dose comprenant en outre un élément d'agitation (40, 140, 240, 340, 440) apte à agiter un mouvement relatif par rapport au réservoir à volume variable (10, 110, 210, 310, 10 410), le mouvement relatif d'agitation provoquant une agitation de remise en suspension de la suspension pharmaceutique, et l'élément d'agitation (40, 140, 240, 340, 440) est fonctionnellement couplé à l'élément de préparation (30, 130, 230, 330, 430) et configuré pour subir ledit mouvement relatif d'agitation en réponse au fonctionnement de l'élément de préparation (30, 130, 230, 330, 430).